+36.1%
MRNA vs QID
-73.7%
+109.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | QID | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.8% | +7.2% | +4.6% |
| 7D | -1.1% | +1.3% | -2.4% | -0.4% |
| 30D | +126.1% | +2.9% | +123.2% | +129.8% |
| 3M | +190.0% | -0.7% | +190.7% | +192.1% |
| 6M | +157.2% | -29.7% | +186.9% | +123.9% |
| YTD | +388.2% | -27.9% | +416.1% | +333.6% |
| 1Y | +467.0% | -34.6% | +501.6% | +385.3% |
| 3Y | +36.1% | -73.5% | +109.6% | -11.9% |
| All | +36.1% | -73.7% | +109.8% | -11.9% |
Cumulative growth
Daily Returns
Daily percentage return beside QID.
Daily Out/Under-Performance
Portfolio return minus QID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded QID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling